Literature DB >> 22733499

T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer.

Danian Tong1, Yujia Zhou, Wei Chen, Yang Deng, Lei Li, Zhenyi Jia, Dachuan Qi.   

Abstract

T cell immunoglobulin- and mucin-domain-containing molecule 3 (TIM-3) is a novel transmembrane protein that is involved in the regulation of T-helper 1 cell-mediated immunity. Studies have shown that polymorphisms in TIM-3 gene can be associated with various diseases. Here, we investigated the correlation of TIM-3 polymorphisms with susceptibility to pancreatic cancer in the Chinese population. Three polymorphisms in TIM-3 gene (-1516G/T, -574G/T, and +4259T/G) were identified by polymerase chain reaction-restriction fragment length polymorphism in 306 pancreatic patients and 408 healthy controls. Results showed that the prevalence of +4259TG genotype and +4259G allele were significantly increased in the pancreatic cancer cases than in controls [odds ratio (OR) = 2.82, 95 % confidence interval (CI), 1.45-5.48, p = 0.0015, and OR = 2.74, 95 % CI, 1.42-2.94, p = 0.0017]. In addition, when analyzing the TIM-3 polymorphisms with different clinical parameters in pancreatic cancer patients, the cases with vascular infiltration had higher numbers of +4259T/G polymorphism than those without vascular infiltration (OR = 3.07, 95 % CI, 1.41-6.68, p = 0.003). These results suggested polymorphisms in TIM-3 gene could be new risk factors for the development of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733499     DOI: 10.1007/s11033-012-1862-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

Review 1.  TIM-1 and TIM-3 proteins in immune regulation.

Authors:  Ee Wern Su; Jean Y Lin; Lawrence P Kane
Journal:  Cytokine       Date:  2008-08-15       Impact factor: 3.861

2.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

Review 3.  Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression.

Authors:  Mario A Shields; Surabhi Dangi-Garimella; Amanda J Redig; Hidayatullah G Munshi
Journal:  Biochem J       Date:  2012-01-15       Impact factor: 3.857

4.  The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.

Authors:  David M Dorfman; Jason L Hornick; Aliakbar Shahsafaei; Gordon J Freeman
Journal:  Hum Pathol       Date:  2010-07-24       Impact factor: 3.466

5.  TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.

Authors:  Yoshikane Kikushige; Takahiro Shima; Shin-ichiro Takayanagi; Shingo Urata; Toshihiro Miyamoto; Hiromi Iwasaki; Katsuto Takenaka; Takanori Teshima; Toshiyuki Tanaka; Yoshimasa Inagaki; Koichi Akashi
Journal:  Cell Stem Cell       Date:  2010-12-03       Impact factor: 24.633

Review 6.  Emerging Tim-3 functions in antimicrobial and tumor immunity.

Authors:  Kaori Sakuishi; Pushpa Jayaraman; Samuel M Behar; Ana C Anderson; Vijay K Kuchroo
Journal:  Trends Immunol       Date:  2011-06-21       Impact factor: 16.687

7.  The association of TIM-3 gene polymorphism with atopic disease in Korean population.

Authors:  Soo-Cheon Chae; Young-Ran Park; Yong-Chul Lee; Jae-Hoon Lee; Hun-Taeg Chung
Journal:  Hum Immunol       Date:  2004-12       Impact factor: 2.850

8.  Expression of the Th1-specific cell-surface protein Tim-3 increases in a murine model of atopic asthma.

Authors:  Wei-Kun Hu; Xiao-Xia Lu; Shuo Yang; Guo-Peng Xu; Fen Lan; Shi-Xin Chen; Wang Ni; Wei-Ning Xiong; Sheng-Dao Xiong
Journal:  J Asthma       Date:  2009-11       Impact factor: 2.515

9.  The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis.

Authors:  Soo-Cheon Chae; Young-Ran Park; Seung-Cheol Shim; Kyung-Sik Yoon; Hun-Taeg Chung
Journal:  Immunol Lett       Date:  2004-08-15       Impact factor: 3.685

Review 10.  The costimulatory role of TIM molecules.

Authors:  Roselynn Rodriguez-Manzanet; Rosemarie DeKruyff; Vijay K Kuchroo; Dale T Umetsu
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

View more
  20 in total

1.  Ex Vivo PD-L1/PD-1 Pathway Blockade Reverses Dysfunction of Circulating CEA-Specific T Cells in Pancreatic Cancer Patients.

Authors:  Yuan Chen; Shao-An Xue; Shahriar Behboudi; Goran H Mohammad; Stephen P Pereira; Emma C Morris
Journal:  Clin Cancer Res       Date:  2017-07-14       Impact factor: 12.531

2.  TIM-3 Genetic Variations Affect Susceptibility to Osteoarthritis by Interfering with Interferon Gamma in CD4+ T Cells.

Authors:  Shufeng Li; Yanjun Ren; Dayong Peng; Zhen Yuan; Shiying Shan; Huaqiang Sun; Xinfeng Yan; Hong Xiao; Guang Li; Haihan Song
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

Review 3.  Targeting novel inhibitory receptors in cancer immunotherapy.

Authors:  Quan-Quan Ding; Joe-Marc Chauvin; Hassane M Zarour
Journal:  Semin Immunol       Date:  2020-12-04       Impact factor: 11.130

Review 4.  Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.

Authors:  Alex B Blair; Adrian Murphy
Journal:  Curr Probl Cancer       Date:  2017-10-31       Impact factor: 3.187

Review 5.  Role of TIM-3 in ovarian cancer.

Authors:  Y Xu; H Zhang; Y Huang; X Rui; F Zheng
Journal:  Clin Transl Oncol       Date:  2017-03-29       Impact factor: 3.405

Review 6.  Tim-3 and its role in regulating anti-tumor immunity.

Authors:  Madhumita Das; Chen Zhu; Vijay K Kuchroo
Journal:  Immunol Rev       Date:  2017-03       Impact factor: 12.988

7.  T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas.

Authors:  Haihan Song; Shaolin Ma; Zhanshan Cha; Lei Chen; Danian Tong; Lan Ma; Weiguo Song; Jianwen Bai
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 8.  Tim-3 and Tim-4 as the potential targets for antitumor therapy.

Authors:  Lin Cheng; Zhihua Ruan
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

9.  Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

Authors:  Keiko Nagahara; Tomohiro Arikawa; Souichi Oomizu; Keiichi Kontani; Atsuya Nobumoto; Hiroaki Tateno; Kota Watanabe; Toshiro Niki; Shigeki Katoh; Minoru Miyake; Syun-Ichiro Nagahata; Jun Hirabayashi; Vijay K Kuchroo; Akira Yamauchi; Mitsuomi Hirashima
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

10.  Significant association between GSTT1 null genotype and susceptibility to pancreatic cancer.

Authors:  Xianmin Bu; Chenghai Zhao
Journal:  Mol Biol Rep       Date:  2013-05-30       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.